FREMONT, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (PSNL), a leader in advanced genomics for precision oncology, today announced Medicare coverage of its ultrasensitive NeXT Personal® test for ...

Coverage marks a pivotal step in expanding access to ultra-sensitive MRD detection for breast cancer patients U.S. Medicare coverage decision reflects published, peer-reviewed clinical data ...

As this report about automation in quality assurance states, ensuring optimal test coverage is among the most arduous tasks in QA. This is because the calculation of this metric depends on a plethora ...

Some private insurers now cover the test with certain limitations, including UnitedHealthcare and Cigna, but others do not. Even in states that have adopted the test, coverage varies. Florida will add ...

TIME IS RUNNING OUT FOR CONGRESS TO APPROVE MEDICARE COVERAGE FOR A SIMPLE BLOOD TEST THAT CAN HELP DETECT CANCER IN EARLIER, MORE TREATABLE STAGES. ADVOCATES TONIGHT SAY WITHOUT MEDICARE COVERAGE, ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it has received new commercial health plan coverage for the ...

DENVER, Sept. 22, 2022 /PRNewswire/ — StackHawk, the company making application security testing part of software delivery, today announced its Deeper API Security Test Coverage release. This expands ...

Cancer test maker Lucid Diagnostics (NASDAQ:LUCD), majority owned by PavMed (NASDAQ:PAVM), traded ~8% lower on Wednesday after the company said that a group of medical experts will meet in September ...

Biotheranostics, a subsidiary of San Diego-based Hologic, has received expanded Medicare coverage of its Breast Cancer Index test. The additional coverage became effective May 10, according to CMS.

It's the first and one of the hardest tests of the Democrats' ambitious plan to overhaul the nation's health care system: establishing a federally funded program in the next 90 days to cover people ...